A detailed history of State Street Corp transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 339,324 shares of ASRT stock, worth $315,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
339,324
Previous 339,324 -0.0%
Holding current value
$315,571
Previous $420,000 4.76%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.75 - $1.31 $895,907 - $1.56 Million
-1,194,543 Reduced 77.88%
339,324 $420,000
Q1 2024

May 15, 2024

BUY
$0.79 - $1.14 $6,492 - $9,368
8,218 Added 0.54%
1,533,867 $1.47 Million
Q4 2023

Feb 14, 2024

BUY
$1.02 - $2.57 $154,142 - $388,378
151,120 Added 10.99%
1,525,649 $1.63 Million
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $1.07 Million - $2.41 Million
422,986 Added 44.45%
1,374,529 $3.52 Million
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $3.85 Million - $5.89 Million
769,579 Added 422.93%
951,543 $5.16 Million
Q1 2023

May 15, 2023

BUY
$3.54 - $6.66 $141,246 - $265,734
39,900 Added 28.09%
181,964 $1.16 Million
Q3 2022

Nov 15, 2022

BUY
$2.13 - $4.0 $19,596 - $36,800
9,200 Added 6.92%
142,064 $322,000
Q2 2022

Aug 15, 2022

SELL
$1.88 - $3.42 $423 - $769
-225 Reduced 0.17%
132,864 $392,000
Q1 2022

May 16, 2022

SELL
$2.06 - $3.0 $53,436 - $77,820
-25,940 Reduced 16.31%
133,089 $382,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $2.3 $13,330 - $35,650
-15,500 Reduced 8.88%
159,029 $347,000
Q3 2021

Nov 15, 2021

SELL
$0.89 - $1.55 $422 - $736
-475 Reduced 0.27%
174,529 $158,000
Q2 2021

Aug 16, 2021

BUY
$1.48 - $2.88 $259,005 - $504,011
175,004 New
175,004 $273,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.